コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ell binding and intracellular trafficking of tetanus toxin.
2 ct mice from challenge with a lethal dose of tetanus toxin.
3 sary component of the receptor mechanism for tetanus toxin.
4 ffected by pretreatment of synaptosomes with tetanus toxin.
5 he complex was insensitive to proteolysis by tetanus toxin.
6 neurotoxin serotypes A, B, and C, as well as tetanus toxin.
7 carboxyl-terminal 34 amino acid residues of tetanus toxin.
8 f protection against a lethal challenge with tetanus toxin.
9 to define the ganglioside-binding domains of tetanus toxin.
10 by unilateral intrahippocampal injection of tetanus toxin.
11 e remaining BoNT serotypes B-G, anthrax, and tetanus toxin.
12 nd ionotropic glutamate receptor blockers or tetanus toxin.
13 or when synaptic transmission is blocked by tetanus toxin.
14 trafficked similarly but not identically to tetanus toxin.
15 with labeling densities similar to those of tetanus toxin.
16 other neurons, similar to the known route of tetanus toxin.
17 radiolabeled GDNF, BDNF, and CT-1 as well as tetanus toxin.
18 E) complexes as judged by its sensitivity to tetanus toxin.
19 nt were protected from lethal challenge with tetanus toxin.
20 lease, as did treatment of the cultures with tetanus toxin (300 ng/ml) to block endogenous neurotrans
22 he observation that transgenic expression of tetanus toxin, a blocker of neurotransmitter release via
23 5-HT(2A/2C) receptor agonist, was blocked by tetanus toxin, a substance that prevents vesicular neuro
25 ptic transmission of select PVT neurons with tetanus toxin activated via retrograde trans-synaptic tr
29 Transient expression of the light chains of tetanus toxin and botulinum toxin A did not disrupt the
32 ion or alpha-latrotoxin and was inhibited by tetanus toxin and by phenylarsine oxide, a phosphoinosit
35 strain which expresses fragment C (ToxC) of tetanus toxin, and (ii) soluble tetanus toxoid (TT) with
36 g the pE88 plasmid, which encodes the lethal tetanus toxin, and thus a potential target for drug desi
37 e this, we exposed a domain of the microbial tetanus toxin antigen (TTCF) to disrupted lysosomes that
42 living motor neurons using a chimera of the tetanus toxin binding fragment (TeNT HC) and a pH-sensit
49 rminal fragment of synaptobrevin released by tetanus toxin, but not its C-terminal membrane-anchored
50 terize the fraction of fluorescently labeled tetanus toxin C fragment bound to a ganglioside-populate
52 n of both native S. aureus enterotoxin B and tetanus toxin C fragment in spiked dilute serum samples.
54 -specific monoclonal antibody fused with the tetanus toxin C fragment was designed and expressed.
56 licited by an adenovirus vector encoding the tetanus toxin C fragment when administered as a nasal or
57 ng this ligand, we observed radiolabeling of tetanus toxin C fragment which could be specifically inh
58 Furthermore, LTIIa binding was blocked by tetanus toxin C fragment, which binds to gangliosides GD
62 mpetitive immunoassay was also developed for tetanus toxin C-fragment by allowing unlabeled and fluor
63 allowing unlabeled and fluorescently labeled tetanus toxin C-fragment compete to bind to a limited fi
65 demonstrate that botulinus toxin type B and tetanus toxin cause a decrease in synaptobrevin II immun
66 ibodies, previously found to protect against tetanus toxin challenge and similar to those observed in
67 Complete protection against in vivo lethal tetanus toxin challenge and the induction of Ag-specific
68 60% of the mice in the BRD937 group survived tetanus toxin challenge if they were preimmunized with B
69 induced protective immune responses against tetanus toxin challenge when applied topically at doses
73 and AA were released solely from neurons as tetanus toxin did not cleave astrocytic synaptobrevin-2,
76 y synthesized with the P30 helper epitope of tetanus toxin, elicited robust LeTx-neutralizing immunit
77 ntigens (beta-galactosidase or fragment C of tetanus toxin) encoded by one plasmid to augment respons
78 Earlier studies implicated a coreceptor for tetanus toxin entry into neurons: a ganglioside binding
83 anding of the neuronal receptors utilized by tetanus toxin for the initial entry into nerve cells.
85 s Typhi and Typhimurium to mucosally deliver tetanus toxin fragment C (Frag C) as a model antigen in
86 HSV) were expressed as C-terminal fusions to tetanus toxin fragment C (TetC) in different Salmonella
87 delivery of a recombinant bacterial vaccine, tetanus toxin fragment C (TTFC) was expressed constituti
88 of recombinant Lactococcus lactis expressing tetanus toxin fragment C (TTFC), which is a known immuno
89 nd spinal cord, we generated a soluble IGF-1:tetanus toxin fragment C fusion protein (IGF-1:TTC) as a
90 In contrast, a similar construct expressing tetanus toxin fragment C under control of the constituti
91 response elicited by CVD 908-htrA expressing tetanus toxin fragment C under the control of the redox-
93 ic neuronal binding domain of tetanus toxin (tetanus toxin fragment C, TTC) has been used as a vector
95 bind plasma proteins, an exogenous protein (tetanus toxin fragment C; TTC), and a viral vector (reco
96 tion stems partly from motor neurone loss, a tetanus toxin fragment-C (TTC) fusion protein was create
97 e have used a pathogen-derived sequence from tetanus toxin (fragment C (FrC)) fused to tumor Ag seque
100 sis of the dendritic trees revealed that the tetanus toxin group showed a decrease in complexity arou
106 rgin females can be blocked by expression of tetanus toxin in Or65a, but not Or67d neurons, demonstra
107 chaemia on the subsequent development of the tetanus toxin-induced epilepsy was studied, using contin
108 oxin-GVIA), intact vesicle fusion processes (tetanus toxin inhibits), and transmitter-filled vesicles
110 ced TNF exocytosis in BMMCs was dependent on tetanus toxin-insensitive vesicle-associated membrane pr
113 In close correlation, microinjection of tetanus toxin into the presynaptic neuron produced a blo
117 ereas Hirudo synaptobrevin is proteolyzed by tetanus toxin, its SNAP-25 isoform is resistant to botul
118 egion- and cell-type-selective expression of tetanus toxin light chain (TeLC) and compared the functi
120 s blocked by both pan-neuronal expression of tetanus toxin light chain (TeTxLC) and by reduction of a
122 or inhibitory (Galpha(i)) Galpha subunit, or tetanus toxin light chain (TNT) in dopamine and serotoni
123 or targeted astrocyte-specific expression of tetanus toxin light chain (to interfere with vesicular r
124 via combinatorial gene expression to deliver tetanus toxin light chain (tox), an inhibitor of vesicul
125 f serotonergic and raphe neurons in mice for tetanus toxin light chain expression, which prevented ve
126 an adenoviral vector to specifically express tetanus toxin light chain in astrocytes) reduced the HVR
127 using Cre-inducible viral expression of the tetanus toxin light chain in male and female PV-Cre mice
129 ng neural activity by targeted expression of tetanus toxin light chain or an inwardly rectifying pota
131 selectively blocked by the expression of the tetanus toxin light chain subunit (TeNT), the regularity
132 naptically silenced by chronic expression of tetanus toxin light chain tagged with cyan fluorescent p
133 nergic neurons, we inactivated them with the tetanus toxin light chain, a genetically encoded inhibit
135 , unc-1(dn) has effects opposite to those of tetanus toxin light chain, separating the roles of ADL e
136 aptic connectivity observed previously after tetanus toxin light chain-dependent blockade of evoked s
138 le-cell pairs demonstrated directly that the tetanus toxin-mediated block of exocytosis is accompanie
142 dorant stimuli, optogenetics, and transgenic tetanus toxin neurotransmission block show that elevated
145 p53, HER2-ICD, HER2-ECD, and CEA, but not to tetanus toxin, relative to controls and surgically resec
147 th presynaptic vesicle fusion by exposure to tetanus toxin reverted functional to silent transmission
149 ced inhibition of early endosome fusion in a tetanus toxin-sensitive manner and removes Hrs from earl
150 rminus or carboxyl terminus of fragment C of tetanus toxin, separated by a 4-amino-acid hinge region.
151 ed by all subjects: one largely overlapped a tetanus toxin sequence region previously identified as a
152 hetic peptides corresponding to the complete tetanus toxin sequence were used to test, in a prolifera
154 ',N'-tetraacetic acid, or the SNARE blocker, tetanus toxin, suggesting Ca2+- and SNARE-dependent fusi
156 copies of a PySSP2 sequence, NPNEPS, and two tetanus toxin T helper epitopes in the adjuvant TiterMax
160 n by different neuronal subtypes, we express tetanus toxin (TeNT) in individual reticulospinal or CoP
163 The non-toxic neuronal binding domain of tetanus toxin (tetanus toxin fragment C, TTC) has been u
164 pressing an unrelated antigen (fragment C of tetanus toxin [TetC]) was also used for immunization as
167 the basis of these analyses, two regions in tetanus toxin that are structurally homologous with the
168 s a non-toxic 47 kDa polypeptide fragment of tetanus toxin that can be used as a subunit vaccine agai
169 Although di- and trisialogangliosides bind tetanus toxin, their role as productive toxin receptors
170 gliosides completely restores the ability of tetanus toxin to bind to the neuronal surface and to blo
171 ion and postsynaptic specialization, we used tetanus toxin to chronically cleave VAMP2 and inhibit SN
173 ely, blocking glutamate release by targeting tetanus toxin to individual synapses increases alpha7-nA
174 f the carboxy-terminal 50 kDa HC fragment of tetanus toxin to polysialogangliosides is important for
175 nditional expression of the light chain from tetanus toxin (tox) in raphe neurons expressing serotone
176 , the motor cortex of rats was injected with tetanus toxin (TT), and gene expression for 67 kDa gluta
177 e separated following rosette formation with tetanus toxin (TT)-coupled immunobeads to study the regu
178 tigated in chronic focal epilepsy induced by tetanus toxin (TT, 20-35 ng) injected in the rat motor c
183 of Ca2+ influx, but in a manner sensitive to tetanus toxin, we find that the secretory process is dir
184 or fused to a fragment C (FrC) sequence from tetanus toxin, we induced both anti-Id and anti-FrC anti
185 /C entered cells differently than the HCR of tetanus toxin, which also utilizes dual gangliosides as
186 tion process is the v-SNARE, VAMP-2, because tetanus toxin, which cleaves VAMP-2, inhibited the forma
187 ion of the receptor binding domain (H(C)) of tetanus toxin, which retains the binding and trafficking
188 rface protein 1 and two T-helper epitopes of tetanus toxin (yP2P30Pv20019), formulated in aluminum hy
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。